⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM)

Official Title: A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma

Study ID: NCT02357147

Study Description

Brief Summary: This study was originally designed as a multicenter, double-blind, randomized, parallel-group study, using a placebo control or amatuximab 5 milligrams per kilogram (mg/kg), administered weekly, designed to evaluate the safety and efficacy of amatuximab in combination with pemetrexed and cisplatin in participants with unresectable Malignant Pleural Mesothelioma (MPM) who have not received prior systemic therapy. Per a business decision made by the Sponsor, participants who were randomized to amatuximab and were still on active treatment at the time of the protocol amendment may have consented to continue to receive weekly treatment with amatuximab until disease progression or intolerable toxicity at the discretion of the principal investigator. Participants randomized to placebo or who were in follow-up at the time of the amendment have been discontinued from the study.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

, La Jolla, California, United States

, Newark, Delaware, United States

, Bethesda, Maryland, United States

, Rochester, Minnesota, United States

, Philadelphia, Pennsylvania, United States

, Dallas, Texas, United States

, Spokane, Washington, United States

, Camperdown, New South Wales, Australia

, Auchenflower, Queensland, Australia

, Richmond, Victoria, Australia

, Perth, Western Australia, Australia

, Caen, , France

, Creteil, , France

, La Tronche, , France

, Lille, , France

, Lyon Cedex, , France

, Marseille, , France

, Rennes, , France

, Toulouse, , France

, Berlin, , Germany

, Esslingen, , Germany

, Frankfurt am Main, , Germany

, Gauting, , Germany

, Hamburg, , Germany

, Hanover, , Germany

, Löwenstein, , Germany

, Ulm, , Germany

, Wöhrendamm, , Germany

, Rozzano, Milano, Italy

, Pisa, Paradisa 2, Italy

, Alessandria, , Italy

, Aviano, , Italy

, Bari, , Italy

, Bergamo, , Italy

, Genoa, , Italy

, Genova, , Italy

, Monza, , Italy

, Orbassano, , Italy

, Parma, , Italy

, Maidstone, Kent, United Kingdom

, Dundee, , United Kingdom

, Hereford, , United Kingdom

, Leicester, , United Kingdom

, London, , United Kingdom

, Middlesex, , United Kingdom

, Preston, , United Kingdom

, Southampton, , United Kingdom

, Swindon, , United Kingdom

, Taunton, , United Kingdom

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: